Sort
4,870 grants matching “glp 1”
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
$613,059Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Sulfamidase Brain Drug Delivery in Sanfilippo Syndrome
$612,428Ruben J. Boado · Armagen Technologies, Inc. · R44 · FY2016 · NS
Sleep deprivation and energy balance
$612,048Marie-Pierre St-Onge · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2008 · HL
Phase 2 Proof-of-Concept Efficacy of BT-11 in Crohn's Disease Patients
$611,918Simon Lichtiger · Landos Biopharma, Inc. · R01 · FY2020 · DK
Prostanoid modulators that reduce brain injury and inflammation after seizures
$611,633Raymond J Dingledine · Emory University · U01 · FY2007 · NS
Phase one clinical trial of a novel small molecule EBNA1 inhibitor, VK-2019, in patients with Epstein- Barr positive nasopharyngeal cancer, with pharmacokinetic and pharmacodynamic correlative studies
$611,419A. Dimitrios Colevas · Stanford University · R01 · FY2022 · CA
Iron Chelators Predicated on Desferrithiocin
$611,341Raymond J Bergeron · University Of Florida · R37 · FY2014 · DK
Engineered Glucose Metabolism in Insulin Secreting Cells
$610,956Christopher B Newgard · Duke University · R01 · FY2024 · DK
The role of G protein-dependent and -independent EP3 signaling in beta-cell compensation and diabetes
$610,939Michelle E Kimple · University Of Wisconsin-Madison · R01 · FY2024 · DK
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)
$610,712Kristen J Nadeau · University Of Colorado Denver · R01 · FY2024 · HL
Multi-receptor Targeting of Glioblastoma
$610,326Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2022 · CA
Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer
$610,112Venkatram Reddy Atigadda · University Of Alabama At Birmingham · R01 · FY2025 · CA
Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer
$610,112Venkatram Reddy Atigadda · University Of Alabama At Birmingham · R01 · FY2023 · CA
Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT)
$609,860Melena D. Bellin · University Of Minnesota · R01 · FY2024 · DK
Changes in neural response to eating after bariatric surgery: MRI results
$609,536Thomas A. Wadden · University Of Pennsylvania · R01 · FY2012 · DK
GMP manufacturing and IND Filing of IN-002, a potent inhaled muco-trapping antibody therapy for Respiratory Syncytial Virus
$608,832Jeff T Hutchins · Inhalon Biopharma, Inc. · SB1 · FY2025 · AI
In Vivo - In Vitro: Repurposing Itraconazole for toplical treatment of Basal Cell
$608,798Weill Medical Coll Of Cornell Univ · N01 · FY2013 · CA
The thrombospondin1-TGF-beta axis in multiple myeloma
$608,247Joanne E Murphy-Ullrich · University Of Alabama At Birmingham · R01 · FY2014 · CA
First-in-human clinical translation of a near-infrared, nerve-specific fluorophore to facilitate tissue-specific fluorescence-guided surgery
$607,951Eric R Henderson · Dartmouth-Hitchcock Clinic · R01 · FY2021 · NS
Neural Bases of Cephalic Phase Endocrine Responses
$607,797Alan C Spector · Florida State University · R01 · FY2021 · DK
Sleep deprivation and energy balance
$607,191Marie-Pierre St-Onge · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2010 · HL
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
$606,985David A Ehrmann · University Of Chicago · U01 · FY2012 · DK
Sleep deprivation and energy balance
$606,239Marie-Pierre St-Onge · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2009 · HL
Individual and Group Career Development Program
$605,718Jennifer Snyder · University Of Maryland Baltimore · U54 · FY2012 · AI
STTR Phase II: Advance Early Detection of Lupus Nephritis with ClearGold
$605,187Mengxiao Yu · Clearnano, Inc. · R42 · FY2022 · DK